ERBB2 and neoplasm: Relative to all other risk factors, as demonstrated by sample size-adjusted chi-square values, tumor size ≥5 and ≥4 positive ipsilateral axillary nodes were the most influential risk factors on mortality for the HR+, HER2+ and HR-, HER2+ subtypes (Fig 4B).